ReviewJournal of clinical medicine2022

Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Use for Atherogenic Dyslipidemia in Solid Organ Transplant Patients.

Gianluigi Cuomo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.